Germantown-based Senseonics develops and commercializes Eversense, an implantable continuous glucose monitoring system designed to provide real-time diabetes data through a sensor placed under the skin. Its Eversense 365 system is designed to last for up to one year, with a removable, rechargeable smart transmitter and mobile app for glucose tracking. Senseonics describes Eversense as the first and only long-term implantable CGM platform.
One Health BiosensingOne Health Biosensing is developing an intradermal continuous glucose monitoring system built around a microneedle sensing platform that sits in the skin without piercing it. Its design pairs a reusable battery pod with a daily disposable sensor to lower costs and reduce medical waste, while AI-enabled guidance is intended to help people with type 2 diabetes act on their glucose data. The sensor remains investigational and has not been approved or cleared by the FDA.
LifeScanFor more than 40 years, LifeScan has focused on helping people with diabetes manage their health through glucose-monitoring technology. Its OneTouch brand is used by more than 20 million people worldwide, while the company’s work also includes digital health solutions and hospital systems for diabetes care.MALVERN, PA
iWel Health InciWel Health is an Exton, Pennsylvania biosensing company whose leadership brings deep experience from Pfizer, Bayer and the medical-device field. It develops continuous glucose monitoring technology for metabolic-health coaching, with particular attention to wellness users and people managing prediabetes or Type 2 diabetes.EXTON, PA
SensarsSensars develops implantable neuroprosthetic and neurostimulation systems designed to restore protective sensation in people with diabetic neuropathy and limb loss. Its SENSY platform combines nerve-implanted electrodes with smart wearable insoles, and preliminary human trials have demonstrated sensory restoration, improved gait and reduced pain. The Swiss-founded company’s work has appeared in more than 25 peer-reviewed publications and received FDA Breakthrough Device Designation.